And Abbott Laboratories presented a first-in-humans study of a new stent that is reabsorbed into the body, potentially removing many of the risks of having a piece of metal sit permanently in an artery.

FORBES

And Abbott Laboratories (nyse: ABT - news - people ) presented a first-in-humans study of a new stent that is reabsorbed into the body, potentially removing many of the risks of having a piece of metal sit permanently in an artery.

FORBES: Selling Stent Safety